Coronary angioplasty versus repeat coronary artery bypass grafting for patients with previous bypass surgery

Mid American Heart Institute, Saint Luke's Hospital, Kansas City, Missouri, USA.

OBJECTIVES: We attempted to determine the relative risks and benefits of percutaneous transluminal coronary angioplasty (PTCA) and repeat coronary artery bypass grafting (re-CABG) in patients with previous coronary bypass surgery (CABG). BACKGROUND: Due to an expanding population of patients with surgically treated coronary artery disease and the natural progression of atherosclerosis, an increasing number of patients with previous CABG require repeat revascularization procedures. Although there are randomized comparative data for CABG versus medical therapy and, more recently, versus PTCA, these studies have excluded patients with previous CABG. METHODS: We retrospectively analyzed data from 632 patients with previous CABG who required either elective re-CABG (n = 164) or PTCA (n = 468) at a single center during 1987 through 1988. The PTCA and re-CABG groups were similar with respect to gender (83% vs. 85% male), age > 70 years (21% vs. 23%), mean left ventricular ejection fraction (46% vs. 48%), presence of class III or IV angina (70% vs. 63%) and three-vessel coronary artery disease (77% vs. 74%). RESULTS: Complete revascularization was achieved in 38% of patients with PTCA and 92% of those with re-CABG (p < 0.0001). The in-hospital complication rates were significantly lower in the PTCA group: death (0.3% vs. 7.3%, p < 0.0001) and Q wave myocardial infarction (MI) (0.9% vs. 6.1%, p < 0.0001). Actuarial survival was equivalent at 1 year (PTCA 95% vs. re-CABG 91%) and 6 years (PTCA 74% vs. re-CABG 73%) of follow-up (p = 0.32). Both procedures resulted in equivalent event-free survival (freedom from dealth or Q wave MI) and relief of angina; however, the need for repeat percutaneous or surgical revascularization, or both, by 6 years was significantly higher in the PTCA group (PTCA 64% vs. re-CABG 8%, p < 0.0001). Multivariate analysis identified age > 70 years, left ventricular ejection fraction < 40%, unstable angina, number of diseased vessels and diabetes mellitus as independent correlates of mortality for the entire group. CONCLUSIONS: In this nonrandomized series of patients with previous CABG requiring revascularization, an initial stategy of either PTCA or re-CABG resulted in equivalent overall survival, event-free survival and relief of angina. PTCA offers lower procedural morbidity and mortality risks, although it is associated with less complete revascularization and a greater need for subsequent revascularization procedures.

This article has been cited by other articles:

				A. R. Kamdar, T. A. Meadows, E. E. Roselli, E. Z. Gorodeski, R. J. Curtin, J. F. Sabik, P. Schoenhagen, R. D. White, B. W. Lytle, S. D. Flamm, et al. Multidetector Computed Tomographic Angiography in Planning of Reoperative Cardiothoracic Surgery Ann. Thorac. Surg., April 1, 2008; 85(4): 1239 - 1245. [Abstract] [Full Text] [PDF]

				S. J. Brener, B. W. Lytle, I. P. Casserly, S. G. Ellis, E. J. Topol, and M. S. Lauer Predictors of revascularization method and long-term outcome of percutaneous coronary intervention or repeat coronary bypass surgery in patients with multivessel coronary disease and previous coronary bypass surgery Eur. Heart J., February 2, 2006; 27(4): 413 - 418. [Abstract] [Full Text] [PDF]

				P. M. Davierwala, M. Maganti, and T. M. Yau Decreasing significance of left ventricular dysfunction and reoperative surgery in predicting coronary artery bypass grafting-associated mortality: A twelve-year study J. Thorac. Cardiovasc. Surg., November 1, 2003; 126(5): 1335 - 1344. [Abstract] [Full Text] [PDF]

				V. Mathew, S.H. Wilson, G.W. Barsness, R.L. Frye, R. Lennon, and D.R. Holmes Comparative outcomes of percutaneous coronary interventions in diabetics vs non-diabetics with prior coronary artery bypass grafting Eur. Heart J., September 2, 2002; 23(18): 1456 - 1464. [Abstract] [Full Text] [PDF]

				M. Labinaz, R. Kilaru, K. Pieper, S. P. Marso, M. M. Kitt, M. L. Simoons, R. M. Califf, E. J. Topol, P. W. Armstrong, and R. A. Harrington Outcomes of Patients With Acute Coronary Syndromes and Prior Coronary Artery Bypass Grafting: Results From the Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy (PURSUIT) Trial Circulation, January 22, 2002; 105(3): 322 - 327. [Abstract] [Full Text] [PDF]

				E. C. Keeley, C. A. Velez, W. W. O'Neill, and R. D. Safian Long-term clinical outcome and predictors of major adverse cardiac events after percutaneous interventions on saphenous vein grafts J. Am. Coll. Cardiol., September 1, 2001; 38(3): 659 - 665. [Abstract] [Full Text] [PDF]

				K. Suehiro, J. Shimizu, G.-H. Yi, S.-M. Zhu, A. Gu, R. R. Sciacca, J. Wang, and D. Burkhoff Direct coronary artery perfusion from the left ventricle J. Thorac. Cardiovasc. Surg., February 1, 2001; 121(2): 0307 - 315. [Abstract] [Full Text] [PDF]

				T. M. Yau, M. A. Borger, R. D. Weisel, and J. Ivanov The changing pattern of reoperative coronary surgeryTrends in 1230 consecutive reoperations J. Thorac. Cardiovasc. Surg., July 1, 2000; 120(1): 156 - 163. [Abstract] [Full Text] [PDF]

				T. V. Bilfinger, J. A. Vosswinkel, C. M. Rialas, I. B. Krukenkamp, and G. B. Stefano Functional assessment of disease-free saphenous vein grafts at redo coronary artery bypass grafting Ann. Thorac. Surg., April 1, 2000; 69(4): 1183 - 1187. [Abstract] [Full Text] [PDF]

				I. Shapira, A. Isakov, I. Heller, M. Topilsky, and A. Pines Long-term Follow-up After Coronary Artery Bypass Grafting Reoperation Chest, June 1, 1999; 115(6): 1593 - 1597. [Abstract] [Full Text] [PDF]